14-alpha Demethylase Inhibitors
Showing 1 - 25 of >10,000
Candidemia, Mycoses, Fungal Infection Trial in Worldwide (Rezafungin for Injection, Posaconazole, Fluconazole)
Recruiting
- Candidemia
- +9 more
- Rezafungin for Injection
- +5 more
-
Brugge, West Vlaanderen, Belgium
- +24 more
Jan 20, 2022
Benign Prostatic Hyperplasia Trial (Phosphodiesterase 5 Inhibitors, Alpha Blockers, Combined Alpha Blockers and
Not yet recruiting
- Benign Prostatic Hyperplasia
- Phosphodiesterase 5 Inhibitors
- +2 more
- (no location specified)
Feb 10, 2022
Myelofibrosis Trial in Hong Kong (Bomedemstat)
Recruiting
- Myelofibrosis
-
Hong Kong, Hong KongDepartment of Medicine, the University of Hong Kong, Queen Mary
Oct 3, 2022
Candidemia, Mycoses, Fungal Infection Trial in Worldwide (Rezafungin for Injection, Caspofungin, Fluconazole)
Completed
- Candidemia
- +3 more
- Rezafungin for Injection
- +4 more
-
Birmingham, Alabama
- +131 more
Dec 13, 2022
Lung Transplant; Complications Trial in Chicago (Etanercept Injection [Enbrel])
Enrolling by invitation
- Lung Transplant; Complications
- Etanercept Injection [Enbrel]
-
Chicago, IllinoisNorthwestern University
Jul 10, 2023
Patients With COVID-19 Pneumonia Will Allow to Detect an Absolute Reduction in the Rate of Respiratory-failure Trial in Milano
Completed
- Patients With COVID-19 Pneumonia Will Allow to Detect an Absolute Reduction in the Rate of Respiratory-failure
- Defibrotide Injection
-
Milano, Lombardia, ItalyOspedale San Raffaele
Jul 18, 2022
Immunogenicity of TNF Inhibitors in Arthritis Poorer Treatment
Recruiting
- Arthritis, Rheumatoid
- +2 more
-
Aalborg, DenmarkDepartment of rheumatology
Sep 1, 2022
Delirium Trial in Birmingham (Guanfacine, Placebo)
Recruiting
- Delirium
- Guanfacine
- Placebo
-
Birmingham, AlabamaUniversity of Alabama at Birmingham Hospital
Nov 17, 2021
MDD Trial in Shibeen Elkom (Roflumilast 250Mcg Tab, Placebo)
Recruiting
- Major Depressive Disorder
- Roflumilast 500Mcg Tab
- Placebo
-
Shibeen Elkom, Menoufia, EgyptFaculty of Pharmacy
Jan 16, 2023
Postoperative Atrial Fibrillation Trial (Discontinuance of treatment with statins 7 to 14 days prior to surgery until 30 days
Recruiting
- Postoperative Atrial Fibrillation
- Discontinuance of treatment with statins 7 to 14 days prior to surgery until 30 days postoperative
- No-intervention.
-
Odense, DenmarkOdense University Hospital
Sep 30, 2022
Hypertension, Mineralocorticoid Excess Trial in Boston (Eplerenone, Amlodipine)
Recruiting
- Hypertension
- Mineralocorticoid Excess
-
Boston, MassachusettsBrigham and Women's
Jul 20, 2022
NSCLC, Low Dose Radiotherapy, Stereotactic Body Radiotherapy Trial in Chengdu (Low Dose Radiotherapy, stereotactic body
Not yet recruiting
- NSCLC
- +3 more
- Low Dose Radiotherapy
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Nov 11, 2022
NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in Lexington (Immune checkpoint inhibitor, Radiation Therapy)
Recruiting
- Non-small Cell Lung Cancer
- Squamous Cell Carcinoma of the Head and Neck
- Immune checkpoint inhibitor
- Radiation Therapy
-
Lexington, KentuckyUniversity of Kentucky Markey Cancer Center
Nov 10, 2022
Melanoma Trial in Boulogne-Billancourt (venous puncture, tumoral biopsy)
Recruiting
- Melanoma
- venous puncture
- tumoral biopsy
-
Boulogne-Billancourt, FranceDermato-oncology department, Ambroise Paré hospital, APHP
Feb 9, 2022
Anesthesia Trial in Cairo (Dexmedetomidine 0.5 mic/kg/h, Fentanyl 1 mic/kg/hr)
Recruiting
- Anesthesia
- Dexmedetomidine 0.5 mic/kg/h
- Fentanyl 1 mic/kg/hr
-
Cairo, EgyptKasr Al Ainy School of Medicine Cairo University
Apr 10, 2022
Axial Spondyloarthritis, Arthritis, Rheumatoid Trial in Portugal (biological disease-modifying antirheumatic drugs (bDMARDs))
Recruiting
- Axial Spondyloarthritis
- Arthritis, Rheumatoid
- biological disease-modifying antirheumatic drugs (bDMARDs)
-
Aveiro, Portugal
- +9 more
Jul 12, 2021
Blocking TNF to Potentiate ICI-dependent Immune Awakening in
Recruiting
- Melanoma
- +2 more
-
Toulouse, FranceInstitut Claudius Regaud
May 25, 2023
Aicardi-Goutières Syndrome Trial in Edinburgh (Abacavir (ABC), Lamivudine (3TC), Abacavir (ABC)+Lamivudine (3TC)+Zidovudine
Recruiting
- Aicardi-Goutières Syndrome
- Abacavir (ABC)
- +2 more
-
Edinburgh, United KingdomYanick Crow
Aug 26, 2022
Pancreatitis, Chronic; Diabetes; Transplant Trial in Minneapolis (etanercept, Alpha 1-Antitrypsin)
Active, not recruiting
- Pancreatitis, Chronic; Diabetes; Transplant
- etanercept
- Alpha 1-Antitrypsin
-
Minneapolis, MinnesotaUniversity of Minnesota
Aug 12, 2022
Acute-graft-versus-host Disease Trial in Worldwide (Alpha-1 antitrypsin (AAT), Placebo)
Recruiting
- Acute-graft-versus-host Disease
- Alpha-1 antitrypsin (AAT)
- Placebo
-
Scottsdale, Arizona
- +19 more
Sep 8, 2022
CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)
Not yet recruiting
- CLL/SLL
- lisaftoclax +BTK inhibitor
- BTK inhibitor
- (no location specified)
Oct 26, 2023
Screening for Alpha Thalassemia in Healthy Volunteers
Recruiting
- Alpha Thalassemia
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Helicobacter Pylori Eradication Rate Trial (vonoprazan fumarate + high dose amoxicillin(H-10d), vonoprazan fumarate + low dose
Not yet recruiting
- Helicobacter Pylori Eradication Rate
- vonoprazan fumarate + high dose amoxicillin（H-10d）
- +2 more
- (no location specified)
Jan 31, 2023
Frontal Alpha Asymmetry and Pediatric Emergence Delirium
Not yet recruiting
- Emergence Delirium
- Ophthalmic surgery
- General anesthesia
- (no location specified)
Apr 5, 2023